Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2013Journal of Korean Medical ScienceOpen Access

QTc longer than 0.508 sec was a cut-off value for major cardiac events (sensitivity 0.806, specificity 0.600), and beta-blocker therapy significantly reduced the longest QTc interval (0.536 ± 0.079 sec vs 0.492 ± 0.061 sec, p=0.007).

View Full Paper
Ask AI
Bookmark
Share

Population

81 Korean patients, comprising 62 probands and 19 family members with LQT gene mutation. Proband median age…

Design

Cohort

Follow-up

mean 4.2 ± 3.5 years

Authors

YLYun‐Sik LeePusan National UniversityBKBo-Sang KwonSeoul National UniversityGKGi Beom KimSeoul National University

Discussion

Loading...

Member takes

Overview

May aid LQTS risk stratification in Koreans; leaves open beta-blocker outcome benefit pending prospective trials.

Key Points

  • Investigate the clinical features, genetic profiles, and treatment responses in Korean patients diagnosed with congenital long QT syndrome and their family members.
  • Evaluated 62 probands with long QT syndrome (QTc ≥ 0.47 sec) and 19 family members at a single center in Korea.
  • Performed genetic screening in 61 individuals and analyzed clinical presentations, ECG variables, and responses to beta-blockers and implantable cardioverter defibrillators.
  • Identified causative genetic mutations in 40 of 61 tested patients (KCNQ1 in 19, KCNH2 in 10, SCN5A in 7, KCNJ2 in 3, CACNA1C in 1), showing 57.9% penetrance in families.
  • QTc was significantly prolonged in patients with syncope (P=0.001), ventricular tachycardia (P=0.017), and aborted cardiac arrest (P=0.010), with QTc > 0.508 sec predicting major cardiac events (sensitivity 0.806, specificity 0.600).
  • Beta-blocker therapy produced a significant reduction in QTc intervals (P=0.007), while implantable cardioverter defibrillators were required in 6 high-risk patients.

Structured PICO

P
Population
81 Korean patients, comprising 62 probands (QTc ≥ 0.47 sec or positive genetic test for LQTS) and 19 family members with LQT gene mutation. Proband median age 15.8 years, 54.8% female.
I
Intervention
Beta-blocker therapy (prescribed in 66.1% of probands and 31.6% of family members) and implantable cardioverter-defibrillator (ICD) implantation (in 6 patients).
O
Outcome
Major cardiac events (composite of syncope, ventricular tachycardia, and aborted cardiac arrest) and reduction in longest QTc interval.composite

In a Korean cohort with Long QT Syndrome, a QTc > 0.508 sec was predictive of major cardiac events, and beta-blocker therapy effectively reduced QTc intervals.

Limitations

  • small sample size

Cite This Study

Lee et al. (2013) studied this question.

synapsesocial.com/papers/6a1e42b040bc8a3dd768aff0https://doi.org/10.3346/jkms.2013.28.10.1454
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Moleculogenetic Characteristics of the Patient with Long QT Syndrome in Korean2004 · 4 citations
  2. 2CLINICAL AND GENETIC CHARACTERISTICS OF LONG QT SYNDROME: A SINGLE-CENTER ANALYSIS2026
  3. 3Congenital and Acquired Long QT Syndrome2004 · 113 citations
  4. 4Clinical and Genetic Characteristics of 18 Cases with Suspected Congenital Long QT Syndrome: A Retrospective Cross-Sectional Study2024 · 2 citations
  5. 5Long QT Syndrome2008 · 655 citations